JP2026041886A5 - - Google Patents
Info
- Publication number
- JP2026041886A5 JP2026041886A5 JP2025230606A JP2025230606A JP2026041886A5 JP 2026041886 A5 JP2026041886 A5 JP 2026041886A5 JP 2025230606 A JP2025230606 A JP 2025230606A JP 2025230606 A JP2025230606 A JP 2025230606A JP 2026041886 A5 JP2026041886 A5 JP 2026041886A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- refamulin
- prodrug
- solvate
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011474P | 2020-04-17 | 2020-04-17 | |
| US63/011,474 | 2020-04-17 | ||
| EP20170072 | 2020-04-17 | ||
| EP20170072.1 | 2020-04-17 | ||
| EP20183292 | 2020-06-30 | ||
| EP20183292.0 | 2020-06-30 | ||
| JP2022562465A JP2023522644A (ja) | 2020-04-17 | 2021-04-16 | プレウロムチリンの治療的使用 |
| PCT/EP2021/025140 WO2021209174A1 (en) | 2020-04-17 | 2021-04-16 | Therapeutic use of pleuromutilins |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562465A Division JP2023522644A (ja) | 2020-04-17 | 2021-04-16 | プレウロムチリンの治療的使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026041886A JP2026041886A (ja) | 2026-03-10 |
| JP2026041886A5 true JP2026041886A5 (enExample) | 2026-05-19 |
Family
ID=75801547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562465A Pending JP2023522644A (ja) | 2020-04-17 | 2021-04-16 | プレウロムチリンの治療的使用 |
| JP2025230606A Pending JP2026041886A (ja) | 2020-04-17 | 2025-12-04 | プレウロムチリンの治療的使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562465A Pending JP2023522644A (ja) | 2020-04-17 | 2021-04-16 | プレウロムチリンの治療的使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230174472A1 (enExample) |
| EP (1) | EP4135682A1 (enExample) |
| JP (2) | JP2023522644A (enExample) |
| CN (1) | CN115443131A (enExample) |
| BR (1) | BR112022020007A2 (enExample) |
| CA (1) | CA3180535A1 (enExample) |
| IL (1) | IL297268A (enExample) |
| TW (1) | TW202203908A (enExample) |
| WO (1) | WO2021209174A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4475834A1 (en) | 2022-02-09 | 2024-12-18 | Nabriva Therapeutics GMBH | Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria |
| EP4338732A1 (en) | 2022-09-16 | 2024-03-20 | Nabriva Therapeutics GMBH | Lefamulin and its derivatives for use in the treatment of tularemia |
| CN119925362A (zh) * | 2023-11-03 | 2025-05-06 | 阳光安津(南京)生物医药科技有限公司 | 一种化合物在制备用于治疗银屑病的药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298733B1 (en) * | 2005-06-27 | 2016-05-25 | Nabriva Therapeutics AG | Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
| EP1972618A1 (en) * | 2007-03-20 | 2008-09-24 | Nabriva Therapeutics AG | Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| GB0803707D0 (en) | 2008-02-28 | 2008-04-09 | Cambridge Entpr Ltd | Antiviral agent |
| EP2399904A1 (en) | 2010-05-26 | 2011-12-28 | Nabriva Therapeutics AG | Process for the preparation of pleuromutilins |
| CN103204787B (zh) | 2012-01-17 | 2014-10-01 | 北京艾百诺科技有限公司 | 含有取代方酸的乙酸妙林酯及其应用 |
| CN103242210B (zh) | 2012-02-09 | 2014-09-24 | 北京艾百诺科技有限公司 | 含有取代方酸的乙酸妙林酯及其应用 |
| KR102656841B1 (ko) | 2015-06-17 | 2024-04-12 | 나브리바 테라퓨틱스 게엠베하 | 레파뮬린의 주사가능한 약제학적 제형 |
| CN110507823B (zh) * | 2019-08-20 | 2021-08-24 | 中国医学科学院基础医学研究所 | 衣康酸相关物质在诊断、防治病毒感染性疾病中的应用 |
-
2021
- 2021-04-16 JP JP2022562465A patent/JP2023522644A/ja active Pending
- 2021-04-16 EP EP21723641.3A patent/EP4135682A1/en active Pending
- 2021-04-16 IL IL297268A patent/IL297268A/en unknown
- 2021-04-16 TW TW110113773A patent/TW202203908A/zh unknown
- 2021-04-16 US US17/919,200 patent/US20230174472A1/en active Pending
- 2021-04-16 CN CN202180028994.6A patent/CN115443131A/zh active Pending
- 2021-04-16 WO PCT/EP2021/025140 patent/WO2021209174A1/en not_active Ceased
- 2021-04-16 BR BR112022020007A patent/BR112022020007A2/pt not_active Application Discontinuation
- 2021-04-16 CA CA3180535A patent/CA3180535A1/en active Pending
-
2025
- 2025-12-04 JP JP2025230606A patent/JP2026041886A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100621281B1 (ko) | 니메설라이드를 포함하는 방출제어형 조성물 | |
| US6433027B1 (en) | Medicament compositions based on tiotropium bromide and formoterol fumarate | |
| JP2007506775A5 (enExample) | ||
| JP2018517715A5 (enExample) | ||
| KR20070102659A (ko) | 베타작용제의 이성체 및 항-콜린제를 포함하는 약제학적조성물 | |
| JP2020523335A5 (enExample) | ||
| EP2822560A1 (en) | Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine | |
| JP2021525746A5 (enExample) | ||
| JP2023521887A5 (enExample) | ||
| JP2019529570A (ja) | ミドドリンの組成物およびその使用方法 | |
| JP2021532193A5 (enExample) | ||
| KR20250040090A (ko) | 액상 약제학적 조성물 | |
| KR101923403B1 (ko) | 리마프로스트 또는 리마프로스트 알파엑스를 함유한 경구용 서방성 제제 조성물 | |
| KR20020050249A (ko) | 포스포디에스테라제 4 억제제의 투여 방법 | |
| CA2827299A1 (en) | Liquid propellant-free formulation comprising an antimuscarinic drug | |
| JP2008533022A5 (enExample) | ||
| JP2023522644A (ja) | プレウロムチリンの治療的使用 | |
| JP2024528731A (ja) | 眼癌転移を予防するためのイブジラスト | |
| CN105147703B (zh) | 黄柏酮在制备防治溃疡性结肠炎的药物中的应用 | |
| KR20150002774A (ko) | 아르포르모테롤 및 플루티카손 푸로에이트를 포함하는 약학 조성물 | |
| CN111991387A (zh) | 去氢二异丁香酚在制备防治溃疡性结肠炎的药物中的应用 | |
| CN104983728B (zh) | 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| JP7527662B2 (ja) | ピモジドとメトトレキサートの医薬組成物、及びその使用 | |
| EP3820526B1 (en) | Combinations of ppar agonists and p38 kinase inhibitors for preventing or treating fibrotic diseases | |
| JP7224624B2 (ja) | 顆粒及びその製造方法 |